Some of the advice comes straight from doctors and pharmacists with social media followings
Summary: Schwannoma = benign, encapsulated, slow-growing, rarely recurs
Common digestive side effects include: Nausea (12-24% of patients): typically most prominent during dose escalation Diarrhea (12-17% of patients): may alternate with constipation in some individuals Decreased appetite : therapeutic effect but can be uncomfortable Vomiting (6-10% of patients): usually transient and dose-related Constipation (5-11% of patients): paradoxically occurs despite overall slowed transit Abdominal pain or discomfort (6-10% of patients) Dyspepsia and bloating : related to delayed gastric emptying These effects are generally most pronounced during the first 4-8 weeks of treatment and during dose escalation periods
Long-term effects: The SURMOUNT-4 trial assessed the long-term maintenance of weight loss
Constipation occasionally develops because reduced appetite means less fiber intake
Esteves, stated that "this collaboration equips healthcare providers with Hypermedica's cutting-edge telehealth tools and comprehensive compounding pharmacy services, ensuring uninterrupted access to affordable, legal, and certified versions of GLP-1 medications
